{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T17:41:26Z","timestamp":1696527686129},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.transproceed.2010.02.061","type":"journal-article","created":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T13:03:01Z","timestamp":1272459781000},"page":"793-796","source":"Crossref","is-referenced-by-count":5,"title":["Mycophenolic Acid Trough Level Measurements and Clinical Outcomes in Kidney Transplantation Recipients on a Fixed Dose (1.5 g\/d) of Mycophenolate Mofetil in Korea"],"prefix":"10.1016","volume":"42","author":[{"given":"S.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Joh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2010.02.061_bib1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ncpneph0225","article-title":"Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts","volume":"2","author":"Liptak","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.transproceed.2010.02.061_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.02.061_bib3","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/00007890-200210270-00002","article-title":"Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine","volume":"74","author":"Flechner","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.02.061_bib4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1600-6143.2004.00404.x","article-title":"Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy","volume":"4","author":"Suwelack","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.02.061_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.02.061_bib6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2010.02.061_bib7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.02.061_bib8","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1097\/01.tp.0000186380.61251.fc","article-title":"The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation","volume":"80","author":"van Gelder","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.02.061_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/01.tp.0000276936.14041.6c","article-title":"The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-0 O-glucuronide","volume":"84","author":"Naesens","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.02.061_bib10","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1681\/ASN.V981511","article-title":"Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients","volume":"9","author":"Weber","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2010.02.061_bib11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/00912700022009260","article-title":"Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable","volume":"40","author":"Shaw","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2010.02.061_bib12","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1016\/j.transproceed.2005.09.202","article-title":"Pharmacokinetics of mycophenolate mofetil in kidney transplant patients with renal insufficiency","volume":"37","author":"Gonzalez-Roncero","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.02.061_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/00912709922008353","article-title":"The effect of renal insufficiency on mycophenolic acid protein binding","volume":"39","author":"Kaplan","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2010.02.061_bib14","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1046\/j.1523-1755.2002.00531.x","article-title":"Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation","volume":"62","author":"Cattaneo","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2010.02.061_bib15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1046\/j.1600-6143.2005.00779.x","article-title":"Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2","volume":"5","author":"Hesselink","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.02.061_bib16","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/S0041-1345(02)03508-X","article-title":"High mycophenolic acid area under-the-curve values in renal transplant recipients on long-term mycophenolate mofetil treatment","volume":"34","author":"Engelbertink","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.02.061_bib17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.103.063073","article-title":"Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats","volume":"309","author":"Kobayashi","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.transproceed.2010.02.061_bib18","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.1600-6143.2009.02668.x","article-title":"Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the opticept trial","volume":"9","author":"Gaston","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.02.061_bib19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1600-6143.2009.02678.x","article-title":"Mycophenolate blood level monitoring: recent progress","volume":"9","author":"van Gelder","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.02.061_bib20","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/TP.0b013e318186f98a","article-title":"Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial","volume":"86","author":"van Gelder","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.02.061_bib21","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1600-6143.2007.01983.x","article-title":"Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation","volume":"7","author":"Le Meur","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.02.061_bib22","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/0091270003256151","article-title":"Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients","volume":"43","author":"Kuypers","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2010.02.061_bib23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00228-001-0389-2","article-title":"Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy","volume":"57","author":"Le Guellec","year":"2002","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510002769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134510002769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T20:33:11Z","timestamp":1635280391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134510002769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0041134510002769"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2010.02.061","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}